The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ipilimumab and nivolumab plus UV1, an anticancer vaccination against telomerase, in advanced melanoma.
 
Paul Lorigan
Stock and Other Ownership Interests - Supportive Care; The Christie Private Care
Honoraria - BMS; Merck; MLA Dx; MSD; NeraCare GmbH; Ultimovacs
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; NeraCare GmbH
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - BMS (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Theresa Medina
Research Funding - Agenus (Inst); BioAtla (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); Day One Biopharmaceuticals (Inst); Genentech (Inst); Immunocore (Inst); InflaRx (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Replimune (Inst); TriSalus Life Sciences (Inst); Ultimovacs (Inst); Xencor (Inst)
 
Marta Nyakas
Consulting or Advisory Role - BMS Norway; BMS Norway; MSD Oncology; MSD Oncology; Novartis
 
Annemie Rutten
Consulting or Advisory Role - Advisory board BMS; Advisory board MSD; Advisory board Pierre Fabre
Travel, Accommodations, Expenses - Travel support MSD; Travel support Pierre Fabre
 
Lynn G. Feun
Research Funding - Merck Sharp & Dohme (Inst)
 
Charles Lance Cowey
Employment - Texas Oncology; US Oncology
Leadership - US Oncology
Consulting or Advisory Role - Iovance Biotherapeutics
Research Funding - Amgen (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst); Seagen (Inst)
 
Miranda Payne
Honoraria - Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Scancell
Speakers' Bureau - Bristol-Myers Squibb; La Roche Posay
 
Israr Hussain
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
 
Timothy Kuzel
Honoraria - Bristol Myers Squibb Foundation; Cardinal Health; CVS; EnGeneIC; Fidia Farmaceutici S. p. A.; Kyowa Kirin International; Merck; SeaGen
Consulting or Advisory Role - enGene
Speakers' Bureau - Genomic Health
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Up to Date Section editor on cutaneous lymphomas
 
Steven O'Day
Employment - Agenus
Leadership - Agenus
Stock and Other Ownership Interests - Agenus
 
Amna Sheri
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - Gilead Sciences
 
Philip Adam Friedlander
Stock and Other Ownership Interests - GE Healthcare; Gilead Sciences; Iovance Biotherapeutics
Consulting or Advisory Role - Castle Biosciences
 
Satish Kumar
Honoraria - JJ Innovative Medicine
Travel, Accommodations, Expenses - Exelixis
 
Jens Bjorheim
Employment - Ultimovacs
Leadership - Ultimovacs
Stock and Other Ownership Interests - Ultimovacs
 
Oliver Edgar Bechter
No Relationships to Disclose